The current randomized clinical trial aimed to compare the outcomes of PPV followed by intravitreal antibiotic injection at the end of surgery versus intravitreal antibiotic injection alone to manage acute PSE, including eyes that had undergone cataract extraction, anti-VEGF injections, bleb-related surgeries, and PPV. The gene discussed is VEGFA; the disease is photosensitive epilepsy.